Escalier Biosciences is developing both topical and oral RORγt inverse agonists for the treatment of a broad spectrum of psoriasis patients – from the underserved mild-to-moderate patients that would benefit from a safe and effective topical RORγt therapeutic to the more moderate-to-severe patients that would benefit from a safe and effective oral RORγt drug in lieu of injectable biologic therapies targeting IL-17 and IL-23.

Biotechnology

Education

Escalier Biosciences

Raju Mohan

Edward Van Wezel

Chris Krueger

John Nuss

The executive team at Escalier Biosciences has experience in a variety of industries, including pharmaceuticals, research, and biotechnology. They have also studied at some of the top schools in the country, including the University of Wisconsin-Madison, the Indian Institute of Technology, and the University of Illinois Urbana-Champaign. This experience and education gives them the knowledge and skills necessary to lead Escalier Biosciences to success.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at Escalier Biosciences

Board of Directors

Leadership Team